- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Beta Drugs Limited held an Extraordinary General Meeting where shareholders approved an increase in the authorized share capital from ₹10 Crore to ₹10.50 Crore, allowing for greater financial flexibility. The approval included issuing 100 equity shares at ₹1,653.40 each and 1,01,651 compulsory convertible debentures (CCDs) at the same price, aggregating to ₹117.02 Crore. This move is expected to enhance the company’s capital structure and support growth initiatives. The special rights accorded to investors aim to strengthen stakeholder involvement, potentially boosting investor confidence with a positive outlook for future capital raises.